PRAME expression stratifies treatment response in NSCLC histologiesPRAME expression predicts opposing treatment outcomes in LUSC vs. LUAD lung cancerINDICATIONLungBIOMARKERPRAMERelated casesIL33 expression as a predictor of immunotherapy response in NSCLCImpact of B cell and CD8 T cell infiltration on immunotherapy outcomes in NSCLCImpact of VEGF expression on pembrolizumab outcomes in mNSCLC
